| BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models X Zhao, Y Ren, M Lawlor, BD Shah, PMC Park, T Lwin, X Wang, K Liu, ... Cancer cell 35 (5), 752-766. e9, 2019 | 68 | 2019 |
| Is optogenetic activation of Vglut1-Positive Aβ low-threshold mechanoreceptors sufficient to induce tactile allodynia in mice after nerve injury? A Chamessian, M Matsuda, M Young, M Wang, ZJ Zhang, D Liu, B Tobin, ... Journal of Neuroscience 39 (31), 6202-6215, 2019 | 31 | 2019 |
| Template-assisted covalent modification of DCAF16 underlies activity of BRD4 molecular glue degraders YD Li, MW Ma, MM Hassan, M Hunkeler, M Teng, K Puvar, R Lumpkin, ... BioRxiv, 2023 | 25 | 2023 |
| Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma X Zhao, MY Wang, H Jiang, T Lwin, PM Park, J Gao, MB Meads, Y Ren, ... Cell reports 34 (11), 2021 | 14 | 2021 |
| Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics MY Wang, P Liow, MIT Guzman, J Qi ACS Chemical Biology 17 (4), 744-755, 2022 | 11 | 2022 |
| Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas J Gao, MY Wang, Y Ren, T Lwin, T Li, JC Yan, EM Sotomayor, DR Duckett, ... Haematologica, 2021 | 8 | 2021 |
| MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas MY Wang, T Li, Y Ren, BD Shah, T Lwin, J Gao, KH Shain, W Zhang, ... Blood Cancer Journal 11 (1), 1-6, 2021 | 6 | 2021 |
| Targeting Kinome Reprogramming for Overcoming Ibrutinib-Resistance (IR) in Mantle Cell Lymphoma (MCL) X Zhao, H Jiang, M Wang, T Li, J Gao, T Lwin, Y Ren, E Sotomayor, ... Blood 132 (Supplement 1), 2651-2651, 2018 | 2 | 2018 |
| CDK9 As a New Therapeutic Vulnerability for Ibrutinib Resistance Mantle Cell Lymphoma (MCL) M Wang, X Zhao, H Jiang, JC Yan, E Sotomayor, KH Shain, B Shah, J Tao Blood 136 (Supplement 1), 34-35, 2020 | 1 | 2020 |
| Identification of synthetic lethal vulnerabilities in cancers with loss of function mutations in NOTCH D Hong, MA Booker, S Anjum, Y Li, TC Thai, MY Wang, DA Barbie, ... Cancer Research 83 (7_Supplement), 5727-5727, 2023 | | 2023 |
| Template-assisted covalent modification of DCAF16 enables BRD4 molecular glue degraders YD Li, MW Ma, MM Hassan, K Puvar, M Teng, B Sandoval, R Lumpkin, ... Cancer Research 83 (7_Supplement), 3424-3424, 2023 | | 2023 |
| MCL1 as a therapeutic vulnerability in Burkitt lymphoma R Yuan, MY Wang, C Bi, X Zhao, J Tao Leukemia 37 (4), 934-937, 2023 | | 2023 |
| Pharmaocogenomic Characterization of MCL-1 Inhibitor Response and Resistance in Aggressive B-Cell Lymphomas M Wang, TL Li, Y Ren, B Shah, T Lwin, J Gao, KH Shain, W Zhang, ... Blood 136 (Supplement 1), 20-21, 2020 | | 2020 |
| (167) Optogenetic control of A-beta low-threshold mechanoreceptors in acute and chronic pain conditions A Chamessian, D Liu, Y Kim, M Wang, Z Zhang, T Van de Ven, R Ji The Journal of Pain 18 (4), S18, 2017 | | 2017 |
